| HOME >> BIOLOGY >> TECHNOLOGY |
Revenue Increase of 19.1%
Improving Full Year Outlook
ORANGE COUNTY, Calif., April 30 /PRNewswire-FirstCall/ -- Beckman
Coulter, Inc. (NYSE: BEC), a leading provider of products that simplify,
automate and innovate biomedical testing, today announced first quarter
ended March 31, 2008 results. Total revenue of $730.5 million rose 19.1%
over first quarter 2007. In constant currency, revenue rose 14.5%. Net
earnings grew 15.6% to $42.9 million, or $0.67 per fully diluted share.
Adjusting for special items, net earnings were $44.0 million, or $0.68 per
fully diluted share, an increase of 4.6% over prior year quarter (See
"Non-GAAP Financial Measures.")
(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO)
Quarter Ended
March 31
2008 2007 % Chg
Reported Results (in millions)
Revenue $730.5 $613.6 19.1%
Net Earnings $42.9 $37.1 15.6%
Earnings per Diluted Share $0.67 $0.59 13.6%
Adjusted Results Excluding
Special Items Earnings per
Diluted Share $0.68 $0.65 4.6%
See "Non-GAAP Financial Measures," where the impacts of certain items on
reported results are discussed.
Scott Garrett, chairman, president and chief executive officer, said,
"First quarter sales were very encouraging. Sales to both Clinical
Diagnostics and Life Scie
'/>"/>
| SOURCE Beckman Coulter, Inc. Copyright©2008 PR Newswire. All rights reserved |